176 related articles for article (PubMed ID: 33078873)
21. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.
Harada H; Harada Y; Kimura A
Curr Cancer Drug Targets; 2006 Sep; 6(6):553-65. PubMed ID: 17017876
[TBL] [Abstract][Full Text] [Related]
22. RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia.
Panagopoulos I; Gorunova L; Jacobsen EM; Andersen K; Micci F; Heim S
PLoS One; 2018; 13(4):e0196181. PubMed ID: 29672642
[TBL] [Abstract][Full Text] [Related]
23. Insights into the prenatal origin of childhood acute lymphoblastic leukemia.
Hein D; Borkhardt A; Fischer U
Cancer Metastasis Rev; 2020 Mar; 39(1):161-171. PubMed ID: 31902036
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
Sun C; Chang L; Zhu X
Oncotarget; 2017 May; 8(21):35445-35459. PubMed ID: 28418909
[TBL] [Abstract][Full Text] [Related]
25. Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.
Harada H; Harada Y
Crit Rev Eukaryot Gene Expr; 2005; 15(3):183-96. PubMed ID: 16390315
[TBL] [Abstract][Full Text] [Related]
26. ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis.
Jakobczyk H; Jiang Y; Debaize L; Soubise B; Avner S; Sérandour AA; Rouger-Gaudichon J; Rio AG; Carroll JS; Raslova H; Gilot D; Liu Z; Demengeot J; Salbert G; Douet-Guilbert N; Corcos L; Galibert MD; Gandemer V; Troadec MB
Leukemia; 2022 Feb; 36(2):549-554. PubMed ID: 34535762
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
28. A minicircuitry of microRNA-9-1 and RUNX1-RUNX1T1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
[TBL] [Abstract][Full Text] [Related]
29. RUNX1 translocations in malignant hemopathies.
De Braekeleer E; Férec C; De Braekeleer M
Anticancer Res; 2009 Apr; 29(4):1031-7. PubMed ID: 19414342
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.
Gao YJ; Zhu XH; Yang Y; Wu Y; Lu FJ; Zhai XW; Wang HS
Cancer Genet Cytogenet; 2007 Oct; 178(1):57-60. PubMed ID: 17889709
[TBL] [Abstract][Full Text] [Related]
31. Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.
Hajingabo LJ; Daakour S; Martin M; Grausenburger R; Panzer-Grümayer R; Dequiedt F; Simonis N; Twizere JC
Mol Biol Cell; 2014 Dec; 25(24):3973-85. PubMed ID: 25273558
[TBL] [Abstract][Full Text] [Related]
32. AML1/RUNX1 gene point mutations in childhood myeloid malignancies.
Migas A; Savva N; Mishkova O; Aleinikova OV
Pediatr Blood Cancer; 2011 Oct; 57(4):583-7. PubMed ID: 21294243
[TBL] [Abstract][Full Text] [Related]
33. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
34. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with
Yun JW; Bae YK; Cho SY; Koo H; Kim HJ; Nam DH; Kim SH; Chun S; Joo KM; Park WY
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959925
[TBL] [Abstract][Full Text] [Related]
35. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
Tsai SC; Shih LY; Liang ST; Huang YJ; Kuo MC; Huang CF; Shih YS; Lin TH; Chiu MC; Liang DC
Clin Cancer Res; 2015 Aug; 21(15):3541-51. PubMed ID: 25840971
[TBL] [Abstract][Full Text] [Related]
36. False positivity of ETV6/RUNX1 detected by FISH in healthy newborns and adults.
Kusk MS; Lausten-Thomsen U; Andersen MK; Olsen M; Hjalgrim H; Schmiegelow K
Pediatr Blood Cancer; 2014 Sep; 61(9):1704-6. PubMed ID: 24740533
[TBL] [Abstract][Full Text] [Related]
37. A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis.
Rae DT; Hocum JD; Bii V; Deeg HJ; Trobridge GD
Oncotarget; 2015 Oct; 6(31):30664-74. PubMed ID: 26384344
[TBL] [Abstract][Full Text] [Related]
38. [Clinical significance of monitoring ETV6-RUNX1 fusion gene expression in children with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Hong Y; Qin YZ; Xu YY; Zhou SH; Wang Y; Xu LP; Zhang XH; Huang XJ; Zhao XS
Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):680-684. PubMed ID: 28954346
[No Abstract] [Full Text] [Related]
39. PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies.
Duhoux FP; Ameye G; Montano-Almendras CP; Bahloula K; Mozziconacci MJ; Laibe S; Wlodarska I; Michaux L; Talmant P; Richebourg S; Lippert E; Speleman F; Herens C; Struski S; Raynaud S; Auger N; Nadal N; Rack K; Mugneret F; Tigaud I; Lafage M; Taviaux S; Roche-Lestienne C; Latinne D; Libouton JM; Demoulin JB; Poirel HA; ;
Br J Haematol; 2012 Jan; 156(1):76-88. PubMed ID: 22050763
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]